Use of a Guinea pig-specific transcriptome array for evaluation of protective immunity against genital chlamydial infection following intranasal vaccination in Guinea pigs
- PMID: 25502875
- PMCID: PMC4263467
- DOI: 10.1371/journal.pone.0114261
Use of a Guinea pig-specific transcriptome array for evaluation of protective immunity against genital chlamydial infection following intranasal vaccination in Guinea pigs
Abstract
Guinea pigs have been used as a second animal model to validate putative anti-chlamydial vaccine candidates tested in mice. However, the lack of guinea pig-specific reagents has limited the utility of this animal model in Chlamydia sp. vaccine studies. Using a novel guinea pig-specific transcriptome array, we determined correlates of protection in guinea pigs vaccinated with Chlamydia caviae (C. caviae) via the intranasal route, previously reported by us and others to provide robust antigen specific immunity against subsequent intravaginal challenge. C. caviae vaccinated guinea pigs resolved genital infection by day 3 post challenge. In contrast, mock vaccinated animals continued to shed viable Chlamydia up to day 18 post challenge. Importantly, at day 80 post challenge, vaccinated guinea pigs experienced significantly reduced genital pathology - a sequelae of genital chlamydial infections, in comparison to mock vaccinated guinea pigs. Sera from vaccinated guinea pigs displayed antigen specific IgG responses and increased IgG1 and IgG2 titers capable of neutralizing GPIC in vitro. Th1-cellular/inflammatory immune genes and Th2-humoral associated genes were also found to be elevated in vaccinated guinea pigs at day 3 post-challenge and correlated with early clearance of the bacterium. Overall, this study provides the first evidence of guinea pig-specific genes involved in anti-chlamydial vaccination and illustrates the enhancement of the utility of this animal model in chlamydial pathogenesis.
Conflict of interest statement
Figures






Similar articles
-
Partial protection against chlamydial reproductive tract infection by a recombinant major outer membrane protein/CpG/cholera toxin intranasal vaccine in the guinea pig Chlamydia caviae model.J Reprod Immunol. 2011 Sep;91(1-2):9-16. doi: 10.1016/j.jri.2011.06.100. J Reprod Immunol. 2011. PMID: 21856018
-
Intranasal vaccination with Chlamydia pneumoniae induces cross-species immunity against genital Chlamydia muridarum challenge in mice.PLoS One. 2013 May 31;8(5):e64917. doi: 10.1371/journal.pone.0064917. Print 2013. PLoS One. 2013. PMID: 23741420 Free PMC article.
-
Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.Infect Immun. 2007 Feb;75(2):666-76. doi: 10.1128/IAI.01280-06. Epub 2006 Nov 21. Infect Immun. 2007. PMID: 17118987 Free PMC article.
-
Chlamydia vaccines: strategies and status.BioDrugs. 2002;16(1):19-35. doi: 10.2165/00063030-200216010-00003. BioDrugs. 2002. PMID: 11908999 Review.
-
Contemporary approaches to designing and evaluating vaccines against Chlamydia.Expert Rev Vaccines. 2003 Feb;2(1):129-46. doi: 10.1586/14760584.2.1.129. Expert Rev Vaccines. 2003. PMID: 12901604 Review.
Cited by
-
An attenuated Machupo virus with a disrupted L-segment intergenic region protects guinea pigs against lethal Guanarito virus infection.Sci Rep. 2017 Jul 5;7(1):4679. doi: 10.1038/s41598-017-04889-x. Sci Rep. 2017. PMID: 28680057 Free PMC article.
-
Guinea pig genital tract lipidome reveals in vivo and in vitro regulation of phosphatidylcholine 16:0/18:1 and contribution to Chlamydia trachomatis serovar D infectivity.Metabolomics. 2016 Apr;12(4):74. doi: 10.1007/s11306-016-0998-5. Epub 2016 Mar 8. Metabolomics. 2016. PMID: 27642272 Free PMC article.
-
Seventy Years of Chlamydia Vaccine Research - Limitations of the Past and Directions for the Future.Front Microbiol. 2019 Jan 31;10:70. doi: 10.3389/fmicb.2019.00070. eCollection 2019. Front Microbiol. 2019. PMID: 30766521 Free PMC article. Review.
-
The effect of infectious dose on humoral and cellular immune responses in Chlamydophila caviae primary ocular infection.PLoS One. 2017 Jul 5;12(7):e0180551. doi: 10.1371/journal.pone.0180551. eCollection 2017. PLoS One. 2017. PMID: 28678871 Free PMC article.
-
Consortium of plant growth-promoting rhizobacteria enhances oilseed rape (Brassica napus L.) growth under normal and saline conditions.Arch Microbiol. 2022 Jun 15;204(7):393. doi: 10.1007/s00203-022-03018-1. Arch Microbiol. 2022. PMID: 35704071
References
-
- Beagley KW, Timms P (2000) Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development. J Reprod Immunol 48:47–68. - PubMed
-
- Waight MT, Rahman MM, Soto P, Tran T (2013) Sexually transmitted diseases during pregnancy in Louisiana, 2007–2009: high-risk populations and adverse newborn outcomes. Journal of the Louisiana State Medical Society 165:219–226. - PubMed
-
- Folger AT (2013) Maternal Chlamydia trachomatis Infections and Preterm Birth: The Impact of Early Detection and Eradication During Pregnancy. Maternal and Child Health Journal. - PubMed
-
- Gaydos CA, Barnes M, Jett-Goheen M, Quinn N, Whittle P, et al. (2013) Characteristics and predictors of women who obtain rescreening for sexually transmitted infections using the www.iwantthekit.org screening programme., International Journal of STD and AIDS 24:736–744. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical